Business

Mass. movers

Aveo Pharmaceuticals stock surges

Aveo’s stock has been rising despite a lack of any specific news. Some see an “Idenix effect.”

Idenix Pharmaceuticals

Aveo’s stock has been rising despite a lack of any specific news. Some see an “Idenix effect.”

Advertisement

Investors are looking closer at Aveo Pharmaceuticals Inc., in part because of the sale of Idenix Pharmaceuticals, the Boston Business Journal says. Aveo’s stock is up 37 percent since June 9 — the day Idenix said it would be bought for more than triple its market value by Merck & Co., the Journal noted. And there’s an Aveo- Idenix connection: A Boston hedge fund, Baupost Group, is the top shareholder of Idenix and the second-largest holder of Aveo stock. Aveo, said Forbes contributor Bryan Rich, has “big potential and billionaire believers.”

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
We hope you've enjoyed your free articles.
Continue reading by subscribing to Globe.com for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com